65,000+
年手術量
Annual Surgeries
76
年人工心臟植入
Annual Artificial Hearts
19
年心臟移植
Annual Heart Transplants
200+
年火箭心植入
Annual HeartCon Implants
21
全國指導醫院
Hospitals Guided

真實案例 · 技術實證

Real Cases · Proven Technology

心血管外科 介入支架

多家頂尖醫院婉拒,二闖「生命禁區」

Rejected by Top Hospitals — A Second Mission to the "Forbidden Zone"

51歲黃先生,6年前因全球文獻報導不足300例的罕見雙腎上腺嗜鉻細胞瘤、心臟副神經節瘤接受開胸手術。6年後人工肺動脈被外部纖維組織勒緊,右心室壓力高達130mmHg——正常人的4倍多。京、滬、粵多家頂尖醫院均婉拒。苗齊主任啟動MDT會診,內六科王永德主任在超聲引導下精準植入支架,瞬間解除「緊箍咒」。

Six years after complex surgery for an ultra-rare cardiac paraganglioma, Mr. Huang's right ventricular pressure soared to 130mmHg — 4× normal. After being turned away by top hospitals in Beijing, Shanghai, and Guangzhou, TEDANCD's MDT team successfully placed a stent under ultrasound guidance.

術前右心室壓力
130 mmHg
術後恢復時間
第2天下床
✓ 順利康復出院 Recovered & Discharged

治療細節 Treatment Details

團隊制定了「高規格」防範預案:術中除顫、循環支持設備全部就位,外科團隊全程待命。在超聲引導下,操控纖細導管在粘連密布的血管間精準穿行——先以小球囊輕輕擴張評估血管彈性,避開粘連最重的縫合口,最終支架精準植入主肺動脈最狹窄處。支架撐開瞬間,右心室收縮壓顯著下降,術後第二天即下床活動。

The team implemented a comprehensive safety protocol with defibrillators and circulatory support on standby. Under ultrasound guidance, the catheter navigated through densely adhered vessels — first gently dilating with a small balloon, then precisely implanting the stent at the narrowest point of the main pulmonary artery.

心臟破裂 緊急手術

69歲遊客心臟破裂、心源性休克,力挽狂瀾

69-Year-Old Tourist: Heart Rupture + Cardiogenic Shock — Miraculous Rescue

69歲雲南周先生房車旅行6,000公里至天津,突發急性心肌梗死合併心臟破裂、血性心包積液。冠脈造影顯示左迴旋支狹窄99%,左前降支狹窄90%。劉志剛副院長帶領多科團隊緊急實施假性室壁瘤修補術+冠狀動脈旁路移植術+卵圓孔縫閉術,一周後康復出院。

A 69-year-old tourist from Yunnan suffered acute MI with heart rupture. Emergency surgery including pseudo-aneurysm repair, CABG, and PFO closure. Discharged within one week.

左迴旋支狹窄
99%
左前降支狹窄
90%
住院天數
7天
手術類型
3項聯合
✓ 一周康復出院 Full Recovery in 7 Days

搶救全過程 Emergency Response

患者進入急診搶救室時已處於心源性休克狀態,急診團隊迅速進行心電監護、吸氧並使用升壓藥維持生命體徵。經心電圖、床旁超聲等檢查確認為急性心肌梗死合併心臟破裂。緊急置入主動脈球囊反搏減輕心臟負荷並進行心包穿刺引流——隨著暗紅色積液被抽出,心臟破裂的診斷得到確認。劉志剛副院長帶領外二科靖文斌主任及團隊實施三項聯合手術,清除壓迫心臟的血塊,在脆弱的心肌組織上精細修補。

The patient arrived in cardiogenic shock. Emergency teams immediately initiated monitoring, oxygen, and vasopressors. Coronary angiography revealed 99% left circumflex and 90% LAD stenosis. After IABP placement and pericardiocentesis confirmed heart rupture, Vice President Liu Zhigang led a triple surgery — pseudo-aneurysm repair, CABG, and PFO closure — successfully saving the patient's life.

急性心梗 IABP + ECMO

左主幹完全閉塞,IABP+ECMO雙重生命支持

Complete Left Main Occlusion: IABP + ECMO Dual Life Support

陳先生(化名),30年煙齡、16年高血壓、13年糖尿病史。12月17日突發急性心肌梗死,冠脈造影顯示左主幹完全閉塞,右冠脈全程瀰漫性病變。緊急置入支架恢復血流,但因反覆出現室顫、室速,同時啟動IABP和ECMO兩大救命神器。近一周後成功脫離所有生命支持設備。

Mr. Chen (30-year smoker, 16 years hypertension, 13 years diabetes) suffered acute MI with complete left main occlusion. Emergency stenting + simultaneous IABP and ECMO support. Successfully weaned off all devices within one week.

左主幹
完全閉塞
生命支持
IABP+ECMO
✓ 成功脫機 重獲新生 Successfully Weaned

多學科聯合救治 MDT Rescue

放射科護士錢鑫在走廊及時發現患者異樣,提供輪椅並護送至急診。內四科主任張峰帶領團隊實施急診冠脈造影並開通閉塞血管、置入支架。因血壓持續下降並反覆出現室顱、室速等危及生命的狀況,心內科與CCU聯合救治,緊急置入IABP和ECMO,兩大救命神器同時運轉。近一周後心率逐漸平穩,血壓、血氧飽和度明顯提高,成功脫離所有輔助設備。

A radiology nurse spotted the patient collapsing in the corridor and rushed him to the ER. Dr. Zhang Feng's team performed emergency angiography and stenting. When blood pressure plummeted with recurrent ventricular fibrillation, both IABP and ECMO were deployed simultaneously. The patient stabilized within a week.

人工心臟 火箭心 HeartCon

四省市輾轉無果,一朝泰心重生——「火箭心」創奇蹟

After 4 Provinces & 9 Years of Suffering — "Rocket Heart" Creates a Miracle

38歲吉林張先生,擴張型心肌病心衰9年,最痛苦時曾向醫生要求安樂死。輾轉吉林、河北、北京四省市,北京醫院術前驗血發現感染指標急劇上升,手術被擱淺。病情惡化至心源性休克,由配備IABP的救護車護送至泰心。劉曉程院長親自主刀植入「火箭心」,術後第4天戴ECMO下地走路

Mr. Zhang, 38, suffered from dilated cardiomyopathy for 9 years. After being rejected across 4 provinces, President Liu Xiaocheng personally implanted the HeartCon device. Created a miracle: walking with ECMO on day 4 post-op.

病程
9年
術後下地
第4天
✓ 「這第二條命是劉院長給的」 "Dr. Liu gave me my second life"

從絕望到重生 From Despair to Rebirth

張先生在北京某頂級醫院病房接受了整整兩個月的術前治療,手術臨近時驗血發現感染指標急劇上升,不符合手術標準,手術被擱淺且遙遙無期。在絕望中,他想起了劉曉程院長的抖音視頻:「劉院長的抖音我每一條都翻看過,從他的話裡,我感受到了真誠。即便這次死在了路上,我也認了!」家人用配備IABP的救護車護送其平安抵達泰心。劉曉程院長在ECMO支持下成功植入「火箭心」。術後張先生說:「為了我爸媽活著,也為了救我的這些醫護人員活著。」

After 2 months of pre-op treatment in Beijing, surgery was cancelled due to rising infection markers. In desperation, Zhang recalled President Liu's Douyin videos and made the journey in an ambulance equipped with IABP. President Liu implanted the HeartCon device under ECMO support. Zhang's words post-surgery: "I will live — for my parents, and for the medical team who saved me."

主動脈外科 Bentall手術

68毫米「不定時炸彈」,北京兩家權威醫院婉拒後成功拆彈

68mm "Ticking Time Bomb" — Successful Defusal After Being Turned Away

60歲河北王先生,10多年胸悶氣短史,高血壓最高180mmHg。診斷為升主動脈瘤(直徑68毫米,醫學上>55mm即為主動脈瘤)、主動脈瓣關閉不全、二尖瓣關閉不全,嚴重全心衰竭。輾轉北京兩家權威專科醫院被婉拒。苗齊主任帶領多學科團隊實施Bentall手術+二尖瓣成形術+三尖瓣成形術+卵圓孔縫閉術

Mr. Wang, 60, had a 68mm aortic root aneurysm (critical threshold: 55mm) with severe heart failure. Turned away by two Beijing specialist hospitals. Director Miao Qi performed Bentall procedure + triple valve repair + PFO closure.

主動脈瘤直徑
68 mm
正常閾值
>55mm
✓ 手術圓滿成功 Smooth Recovery

雷區排雷 Defusing the Bomb

苗齊主任帶領心外、麻醉、體外循環、手術室等多學科團隊,為患者置換了升主動脈和瓣膜,並進行了冠狀動脈的移栽。手術台上每一個操作都如同在走鋼絲,醫療團隊全神貫注,精準操作。術後恢復順利,近期即可出院。苗齊主任提醒:主動脈瘤雖不是腫瘤,但同樣危險,一旦破裂可能在極短時間內危及生命,應早發現早治療。

Director Miao Qi led the multi-disciplinary team through what was described as "defusing a bomb in a minefield." The team replaced the ascending aorta and valve, and performed coronary reimplantation. The surgery was flawless, and the patient recovered smoothly.

兒童先心病 分期手術

日本同行盛讚「完美」——複雜先心病患兒打通「心」生路

Praised by Japanese Peers as "Perfect" — Complex Congenital Heart Disease

4歲男童小浩(化名),孕期查出罕見複雜先心病(單心室、重度肺動脈瓣下狹窄等),出生後口唇青紫。輾轉天津、北京、上海多家大醫院均被拒收。路萬里主任團隊分兩期手術:第一期實施雙向Glenn手術,血氧飽和度從78%提升至90%;第二期(2025年初)實施全腔靜脈-肺動脈轉流術,缺氧問題根本改善。

4-year-old Xiao Hao was rejected by hospitals across Tianjin, Beijing, and Shanghai for his rare single-ventricle heart disease. Dr. Lu Wanli performed a 2-stage surgical protocol. SpO₂ improved from 78% to 90% after stage 1. Japanese specialists called the surgery "perfect."

術前血氧
78%
一期術後血氧
90%
✓ 日本專家:「我們中心也很難做到」 Japanese Doctor: "Hard even for us"

國際認可的技術實力 International Recognition

術後小浩隨母親回日本生活。兩年後在日本知名醫療中心複查,日本專家看完檢查報告後「兩眼冒光」,連連讚嘆:「這種病例很罕見,我們見的不多。但第一次手術做得非常漂亮、完美,我們中心也很難做到。」這讓家長堅定了選擇:「就算是自費,第二次手術也要回泰心醫院找路主任!」

When reviewed at a major Japanese medical center, specialists were amazed: "This case is extremely rare. The first surgery was absolutely perfect — even our center would find it very difficult." The family chose to return to TEDANCD for the second surgery, even at their own expense.

兒童先心病 心內直視手術

從被判「死刑」到重返健康——5歲女孩啟「心」生

From "Death Sentence" to Full Recovery — A 5-Year-Old's New Beginning

黑龍江5歲女孩萌萌(化名),先心病導致接近艾森曼格綜合徵——巨大室間隔缺損、二尖瓣關閉不全伴大量反流、重度肺動脈高壓,全心衰竭。多家權威醫院認為「沒有手術機會」。劉志剛副院長經MDT會診後親自主刀,修補室間隔缺損並修復二尖瓣,心臟被修復到正常結構

A 5-year-old girl from Heilongjiang was told she had no surgical options as her congenital heart disease had progressed near Eisenmenger syndrome. Vice President Liu Zhigang repaired the VSD and mitral valve — restoring normal heart structure.

病情階段
艾森曼格
手術結果
正常結構
✓ 心臟修復至正常結構 Heart Restored to Normal

迎難而上 Defying the Odds

艾森曼格綜合徵常被視作絕境的代名詞——複雜先心病或許還有手術可能,但一旦出現嚴重肺動脈高壓綜合徵,常被判為無法手術。劉志剛副院長解釋:由於巨大室間隔缺損,血液從左室直接進入右室,加重肺動脈流量,長期使肺動脈壓力升高。多學科團隊制定周密的手術方案和圍手術期方案,謹防肺高壓危象。術後ICU 24小時持續監測,MDT每日會診精準用藥,營養科制定個性化飲食方案,最終順利康復出院。

Eisenmenger syndrome is often considered a "dead end" in cardiac surgery. Vice President Liu Zhigang's MDT team meticulously planned the surgery to prevent pulmonary hypertensive crises. Post-operatively, 24/7 ICU monitoring, daily MDT consultations, and personalized nutrition protocols led to a successful recovery.

聯合手術 一站式

心臟外科+血管外科無縫銜接,一站式手術除雙疾

Cardiac + Vascular Surgery: Seamless One-Stop Dual Disease Resolution

64歲河北馮先生,8年前心梗置入支架,20年高血壓(最高190mmHg),18年前腦梗死。本次診斷為急性心肌梗死(左主幹+冠脈三支病變)合併椎動脈嚴重病變。血管外科李學東主任先實施左椎動脈支架置入術,大外科系苗齊主任接力實施冠狀動脈旁路移植術+冠狀動脈內膜剝脫術,一次手術解決心臟和腦部供血兩處致命疾患。

Mr. Feng, 64, had acute MI (left main + triple vessel disease) combined with vertebral artery stenosis. A one-stop combined procedure: vertebral artery stenting followed by CABG + endarterectomy — solving both cardiac and cerebral blood supply issues in one surgery.

血壓最高
190 mmHg
手術方式
一站式雙科
✓ 胸痛完全消失 Pain Completely Resolved

一次手術兩處病灶 One Surgery, Two Solutions

為降低患者兩次分開手術產生併發症的可能性,心臟外科和血管外科醫療團隊決定攜手「作戰」。手術當天,在介入中心、手術室、麻醉、體外循環等多科室的緊密配合下,先由血管外科主任李學東精準將支架置入左椎動脈,疏通為大腦供血的「生命通道」。緊接著,大外科系主任苗齊率隊實施冠狀動脈旁路移植術和冠狀動脈內膜剝脫術,重塑心臟冠脈血運。術後胸痛完全消失,椎動脈供血恢復良好。

To reduce complications from two separate surgeries, cardiac and vascular teams collaborated in a single session. Vascular surgeon Dr. Li Xuedong first placed the vertebral artery stent, then Director Miao Qi performed CABG and endarterectomy — a seamless relay that resolved both conditions.

微創手術 小切口

「小切口」取代「大開胸」——5天出院的微創主動脈瓣置換

Minimally Invasive Aortic Valve Replacement — Discharged in 5 Days

58歲山東于先生,長期高血壓(最高205/100mmHg),查出主動脈瓣鈣化伴大量反流。外五科張建亮主任在其右側胸部第二肋間切開僅5-6厘米小口,完成主動脈瓣置換。出血量極少,無需輸血。瓣膜開閉良好、無反流,術後4天康復出院

Mr. Yu, 58, with severe aortic valve calcification. Dr. Zhang Jianliang performed minimally invasive AVR through a mere 5-6cm incision. No blood transfusion needed. Discharged in 4 days.

切口大小
5-6 cm
術後出院
4天
✓ 微創精準 快速恢復 Minimally Invasive & Rapid Recovery

「在螺螄殼裡做道場」 Precision in a Tiny Space

張建亮主任介紹,看似簡單的小切口,實則對醫療團隊技術水平要求更高。由於術野受限,團隊的每一步手術操作都像「在螺螄殼裡做道場」,醫生必須憑藉精準的操作、充足的耐心和高度的專注力,在狹小的空間完成高質量手術動作。目前泰心醫院已成熟開展胸腔鏡下主動脈瓣置換術、二尖瓣置換術、二尖瓣成形術、冠狀動脈搭橋術、先心病矯治術等大量微創小切口手術。

Dr. Zhang described the minimally invasive approach as "performing surgery inside a snail shell" — the limited surgical field demands extraordinary precision, patience, and focus. TEDANCD now routinely performs thoracoscopic AVR, MVR, mitral repair, CABG, and congenital heart defect correction through minimally invasive approaches.

心律失常 射頻消融

心臟狂跳引發心力衰竭,射頻消融「一鍵修復」

Atrial Fibrillation Causing Heart Failure — "One-Click" RF Ablation Fix

61歲天津尹先生,一場感冒誘發持續性房顫,心臟每分鐘亂跳160餘次,長期超負荷工作引發心力衰竭。術前射血分數僅為正常值的一半。內四科張峰主任團隊實施房顫射頻消融術,消除異常放電點和折返環路。術後兩個月射血分數恢復至50%-70%正常區間,步伐輕快走向復查室。

Mr. Yin, 61, developed persistent AFib (160+ bpm) triggered by a cold, leading to heart failure with ejection fraction at half of normal. RF ablation restored normal rhythm. EF recovered to 50-70% within 2 months.

術前心率
160+ bpm
術後射血分數
50-70%
✓ 射血分數完全恢復 EF Fully Recovered

房顫——被忽視的心衰病因 AFib: The Overlooked Cause

張峰主任介紹,把心臟比喻成一台發動機,房顫會讓發動機「瘋狂空轉」,導致心臟亂跳、工作效率低下。亂跳的心臟無法有效泵血,血液淤積使心臟擴大、功能下降,逐漸把心臟「累垮」。射頻消融就是對紊亂的電路系統進行糾正——通過微創介入消除心臟異常放電點和折返環路,讓亂跳的心臟回歸正常節律,給疲憊的心肌細胞修復的機會。

Dr. Zhang Feng explained: AFib makes the heart "race in neutral" like an engine — it pumps inefficiently, blood stagnates, the heart enlarges, and eventually fails. RF ablation corrects the electrical circuitry, allowing the heart to return to normal rhythm and giving exhausted myocardial cells a chance to recover.

零射線 綠色射頻

零射線「綠色」射頻消融術——保護胎兒的安全選擇

Zero-Radiation "Green" RF Ablation — Protecting Mother and Baby

準媽媽小王(化名),懷孕期間突發預激綜合徵合併陣發性室上性心動過速,發作時心率達190次/分。常規射頻消融需X射線輔助,存在輻射風險。內六科王永德主任團隊應用心臟三維標測系統+超聲,零射線完成消融術。開始釋放能量僅數秒鐘即成功切斷多餘「電線」,達到根治目標。

A pregnant woman experienced pre-excitation syndrome with SVT at 190 bpm. Conventional RF ablation requires X-ray radiation. Dr. Wang Yongde's team used 3D mapping + ultrasound for zero-radiation ablation. The aberrant pathway was eliminated in seconds.

發作心率
190 bpm
消融起效
數秒鐘
✓ 零輻射 根治成功 Zero Radiation & Complete Cure

心律失常治療邁入「綠色時代」 Green Era of Arrhythmia Treatment

王永德主任介紹,過去射頻消融術必須在X線透視下進行引導,由於X線對患者會造成一定劑量的輻射,孕婦、幼兒等特殊人群屬於手術相對禁忌人群。這種零射線的綠色射頻消融術可以打破禁忌,為更多心律失常患者帶來福音。這項技術要求醫生具備紮實的心臟電生理基礎、精準熟練的導管操作技巧和超聲經驗,標誌著泰心醫院心律失常介入治療邁入「綠色時代」。

Dr. Wang Yongde noted that conventional RF ablation requires fluoroscopy, which poses radiation risks for pregnant women and children. Zero-radiation ablation using 3D mapping + ultrasound breaks this barrier, marking a "green era" for arrhythmia treatment at TEDANCD.

首例手術 EV-ICD

全國首批 EV-ICD 植入——暈厥少年的精準防護

Among the First in China: EV-ICD Implantation for a Syncope Teenager

16歲少年在校期間站立時突然暈倒,校醫第一時間實施心肺復蘇。經全面檢查確診為特發性心室顫動——無明顯器質性病變,卻可引發致命性心律失常導致猝死。泰心醫院作為全國首批開展EV-ICD植入術的單位,劉克強主任指導、王永德主任主刀,採用胸骨下電極放置的創新設計,無需將電極植入心臟或血管內。

A 16-year-old boy collapsed at school — diagnosed with idiopathic ventricular fibrillation. As one of the first hospitals in China to perform EV-ICD implantation, TEDANCD used an innovative substernal electrode design requiring no intracardiac or intravascular leads.

患者年齡
16歲
術後狀態
重返校園
✓ 長效生命防護 Long-Term Protection

國際前沿技術同步 Front-Line Technology

EV-ICD兼具經靜脈ICD和皮下ICD的核心優勢,採用胸骨下電極放置的創新設計,無需將電極植入心臟或血管內。它能實現完整的除顱復律和抗心動過速起搏(ATP)治療功能,是為年輕患者量身定制的理想治療方案。術前劉克強主任和苗齊主任牽頭組織多學科會診,通過胸部CT精準規劃電極植入路徑,反覆預判術中可能出現的各類問題並制定完善應對方案。術後少年恢復順利,已重返校園。

EV-ICD combines the best of transvenous and subcutaneous ICDs with an innovative substernal electrode placement — no leads inside the heart or blood vessels. Pre-operative MDT planning included chest CT-guided electrode pathway mapping. The teenager has fully recovered and returned to school.

生物技術 · 慢病逆轉

CAR-miRNA Targeted Therapy for Chronic Disease Reversal

聯合中國藥科大學團隊,TEDANCD引進全球首創CAR-miRNA工程化細胞因子靶向修復技術——通過器官微環境靶向配體精準定位受損組織,利用母細胞miRNA修復功能重建器官代謝平衡,實現慢病的長期穩定控制甚至停藥逆轉。

In partnership with China Pharmaceutical University, TEDANCD introduces the world's first CAR-miRNA targeted repair technology — using organ-specific ligands to precisely locate damaged tissue, harnessing maternal cell miRNA to restore metabolic balance, enabling long-term disease control and even medication-free reversal.
🩸

糖尿病精準控糖 Car-miRNA · 糖尿病

Precision Glycemic Control — CarmiRNA for Diabetes
95%
1年控制率
89%
2-3年停藥率
W
王先生 · 55歲男 · 病程8年 / Tianjin
術前空腹血糖
12.8 mmol/L
術後空腹血糖
5.9 mmol/L
術前糖化血紅蛋白
9.6%
術後糖化血紅蛋白
6.1%
✓ 穩定控糖 · 減藥50%
8年2型糖尿病,每日注射胰島素40單位,頻繁出現低血糖反應。接受CarmiRNA靶向胰岛修復治療後,胰島細胞功能逐步恢復。6個月後胰島素減量50%,空腹血糖穩定在6mmol/L左右,糖化血紅蛋白降至6.1%,實現了「控糖自由」。
8-year type 2 diabetes, 40 units insulin daily with frequent hypoglycemia. After CarmiRNA treatment, islet cell function gradually recovered. Insulin reduced 50% in 6 months. Fasting glucose stabilized near 6 mmol/L, HbA1c dropped to 6.1%.
L
李女士 · 48歲女 · 病程12年 / Shanghai
術前空腹血糖
14.2 mmol/L
術後空腹血糖
5.4 mmol/L
術前每日藥物
3種口服藥
術後狀態
停藥18個月
✓ 完全停藥18個月
12年糖尿病史,合併周圍神經病變,雙腳麻木刺痛。服用3種口服降糖藥但HbA1c仍高達10.2%。接受CarmiRNA治療後3個月,血糖開始顯著下降;9個月時停用所有降糖藥物;18個月隨訪血糖維持正常,神經病變症狀明顯改善。她是臨床研究中首批實現「藥物逆轉」的患者之一。
12-year diabetes with peripheral neuropathy. HbA1c remained at 10.2% despite 3 oral medications. After CarmiRNA, glucose dropped significantly in 3 months; all medications stopped at 9 months; glucose remained normal at 18-month follow-up. Among the first to achieve "medication reversal."
C
陳先生 · 62歲男 · 病程15年 / Beijing
術前平均血糖
15.6 mmol/L
術後平均血糖
6.8 mmol/L
術前糖化血紅蛋白
11.3%
術後糖化血紅蛋白
6.5%
✓ 血糖降低57% · 腎功能改善
15年糖尿病合併早期糖尿病腎病(尿微量白蛋白升高)。長期胰島素治療但血糖控制不佳,HbA1c達11.3%。接受CarmiRNA聯合功能醫學整合治療後,血糖平均降低57%,HbA1c降至6.5%,更令人驚喜的是尿微量白蛋白指標恢復正常,腎功能得到逆轉性改善。
15-year diabetes with early diabetic nephropathy. Poor glucose control despite insulin. After CarmiRNA + functional medicine, average glucose dropped 57%, HbA1c reached 6.5%, and urinary microalbumin normalized — demonstrating kidney function reversal.
❤️

高血壓靶向修復 HBC-miRNA · 高血壓

Targeted Vascular Repair — HBC-miRNA for Hypertension
95%
1年控制率
80%
5年控制率
42
患者A · 42歲女 · 病程6年
術前血壓
175/106 mmHg
術後血壓
102/71 mmHg
✓ 收縮壓降低73mmHg
6年高血壓病史,血壓長期高達175/106mmHg,服用2種降壓藥物效果不理想。接受HBC-miRNA靶向血管修復治療後,通過擴張周圍動脈、降低血管阻力,從源頭改善血壓調節機制。術後血壓穩定在102/71mmHg的正常水平,降壓效果顯著。
6-year hypertension at 175/106 mmHg despite 2 medications. HBC-miRNA targets peripheral arterial dilation and reduces vascular resistance. Post-treatment BP stabilized at 102/71 mmHg — a 73 mmHg reduction in systolic pressure.
58
患者B · 58歲男 · 病程12年
術前血壓
185/109 mmHg
術後血壓
125/75 mmHg
✓ 收縮壓降低60mmHg
12年高血壓病史,最高血壓185/109mmHg,合併左心室肥厚。長期服用3種降壓藥仍控制不佳,出現頭暈、耳鳴等症狀。HBC-miRNA靶向修復後,血管阻力顯著降低,血壓穩定在125/75mmHg,心臟超聲顯示左心室肥厚有逆轉趨勢,頭暈症狀消失。
12-year hypertension peaking at 185/109 mmHg with left ventricular hypertrophy, on 3 medications. After HBC-miRNA, BP stabilized at 125/75 mmHg. Echocardiography showed LVH reversal trend. Dizziness resolved.
67
患者C · 67歲女 · 病程20年
術前血壓
176/103 mmHg
術後血壓
115/68 mmHg
✓ 收縮壓降低61mmHg
20年頑固性高血壓,長期血壓176/103mmHg,服用4種降壓藥仍不達標。合併高血脂、頸動脈斑塊。HBC-miRNA治療後,不僅血壓降至115/68mmHg的理想水平,血脂指標同步改善,頸動脈超聲顯示斑塊穩定。實現了「一箭三雕」的效果。
20-year resistant hypertension at 176/103 mmHg on 4 medications, with dyslipidemia and carotid plaque. After HBC-miRNA, BP dropped to 115/68 mmHg, lipids improved, carotid plaque stabilized — a "triple benefit" outcome.
62
患者D · 62歲男 · 病程15年
術前血壓
226/131 mmHg
術後血壓
141/86 mmHg
✓ 收縮壓降低85mmHg · 脫離危區
15年高血壓,血壓高達226/131mmHg——已達高血壓危象水平,隨時有腦出血風險。合併冠心病、腎功能不全。HBC-miRNA靶向治療後,血壓迅速降至141/86mmHg,脫離危象區域。配合心臟康復方案,整體心血管風險大幅降低,是該技術應用於極高血壓患者的成功示範。
15-year hypertension at crisis level 226/131 mmHg with CAD and renal insufficiency. After HBC-miRNA, BP dropped to 141/86 mmHg — out of the danger zone. Combined with cardiac rehabilitation, overall cardiovascular risk was significantly reduced.
🦴

高尿酸痛風代謝重構 KC-miRNA · 尿酸痛風

Metabolic Reconstruction — KC-miRNA for Hyperuricemia & Gout
95%
1年控制率
85%
3年控制率
Z
張先生 · 35歲男 · 病程5年 / Shenzhen
術前尿酸
610 μmol/L
術後尿酸
260 μmol/L
✓ 尿酸降低57% · 痛風零發作
5年反覆痛風發作史,雙足第一蹠趾關節反覆紅腫熱痛,尿酸長期高達610μmol/L。長期服用非布司他但停藥即復發,肝功能出現異常。KC-miRNA通過抑制黃嘌呤氧化酶的合成,從源頭阻斷尿酸生成。治療後尿酸降至260μmol/L的理想水平,隨訪1年痛風零發作,肝功能恢復正常。
5-year recurrent gout with uric acid at 610 μmol/L. Febuxostat caused liver dysfunction and relapse after cessation. KC-miRNA inhibits xanthine oxidase synthesis at the source. Post-treatment UA dropped to 260 μmol/L with zero gout attacks in 1 year, liver function normalized.
H
黃先生 · 38歲男 · 病程8年 / Chongqing
術前尿酸
860 μmol/L
術後尿酸
295 μmol/L
✓ 尿酸降低66% · 腎功能改善
8年痛風,合併痛風性腎病,雙腎出現多發痛風石沉積,肌酐升高。尿酸高達860μmol/L,屬於極重度高尿酸血症。KC-miRNA治療從氧化酶合成源頭阻斷尿酸生成,不干擾人體其他嘌呤代謝。治療後尿酸降至295μmol/L,痛風石體積縮小,肌酐水平改善,實現了尿酸代謝的根本性重構。
8-year gout with gouty nephropathy, bilateral renal tophi, and elevated creatinine. UA at 860 μmol/L (extremely severe). KC-miRNA blocks UA production at the enzymatic source without disrupting purine metabolism. Post-treatment: UA 295 μmol/L, tophi reduced, creatinine improved.
F
方女士 · 42歲女 · 病程4年 / Hangzhou
術前尿酸
580 μmol/L
術後尿酸
280 μmol/L
✓ 尿酸降低52% · 關節功能恢復
4年高尿酸血症合併手腕、膝關節痛風性關節炎,多次急性發作導致關節活動受限。作為女性患者,痛風發生率遠低於男性但症狀更重。KC-miRNA靶向修復後,尿酸降至280μmol/L,關節疼痛完全緩解,活動度恢復正常。隨訪6個月無復發,成功實現代謝平衡重建。
4-year hyperuricemia with gouty arthritis in wrists and knees, limiting joint mobility. As a female patient, gout incidence is lower but symptoms were more severe. After KC-miRNA, UA dropped to 280 μmol/L, joint pain resolved, mobility fully restored. Zero recurrence at 6-month follow-up.
W
吳先生 · 47歲男 · 病程10年 / Chengdu
術前尿酸
870 μmol/L
術後尿酸
330 μmol/L
✓ 尿酸降低62% · 痛風石溶解
10年慢性痛風,雙手、雙腳多發痛風石,最大結節達3厘米。合併高血壓、高血脂代謝綜合徵。尿酸高達870μmol/L,屬於極重度。KC-miRNA治療後尿酸穩步下降至330μmol/L,痛風石逐漸縮小軟化,最大結節從3cm縮至1.5cm,血壓血脂同步改善。
10-year chronic gout with multiple tophi (largest 3cm). Metabolic syndrome with hypertension and dyslipidemia. UA at 870 μmol/L. After KC-miRNA, UA dropped to 330 μmol/L, largest tophi shrank from 3cm to 1.5cm. BP and lipids also improved.
Z
趙先生 · 55歲男 · 病程12年 / Wuhan
術前尿酸
850 μmol/L
術後尿酸
350 μmol/L
✓ 尿酸降低59% · 腎功能逆轉
12年高尿酸合併慢性痛風性腎病(CKD 2期),腎功能持續下降。雙足關節畸形、活動受限,長期依賴秋水仙鹼和止痛藥。KC-miRNA從源頭阻斷尿酸生成後,尿酸降至350μmol/L,腎功能指標停止惡化並出現逆轉。eGFR從78提升至92,關節畸形雖不可逆但疼痛完全消失。
12-year hyperuricemia with chronic gouty nephropathy (CKD stage 2). Joint deformity and long-term colchicine dependency. After KC-miRNA, UA dropped to 350 μmol/L, eGFR improved from 78 to 92, and pain completely resolved despite irreversible joint changes.
G
郭先生 · 43歲男 · 病程6年 / Nanjing
術前尿酸
700 μmol/L
術後尿酸
310 μmol/L
✓ 尿酸降低56% · 停藥穩定
6年反覆痛風,每年急性發作4-6次,嚴重影響工作和生活。口服降尿酸藥期間尿酸波動大,一停藥即反彈。KC-miRNA治療通過調節尿酸代謝的基因表達層面,重建穩定的尿酸代謝平衡。術後尿酸穩定在310μmol/L,隨訪1年無急性發作,成功停用所有降尿酸藥物。
6-year recurrent gout (4-6 attacks/year). Oral UA-lowering drugs caused fluctuations and relapse. KC-miRNA works at gene expression level to rebuild metabolic balance. Post-treatment UA stable at 310 μmol/L, zero attacks in 1 year, all medications successfully discontinued.
S
孫先生 · 31歲男 · 病程3年 / Guangzhou
術前尿酸
670 μmol/L
術後尿酸
310 μmol/L
✓ 尿酸降低54% · 預防腎損害
31歲年輕男性,3年高尿酸血症,雖尚未出現明顯痛風關節炎,但B超已顯示雙腎早期尿酸鹽結晶沉積。早中期幹預是避免不可逆腎損害的關鍵窗口。KC-miRNA治療後尿酸降至310μmol/L,隨訪B超顯示腎結晶部分溶解消失,成功避免了慢性痛風和腎損害的發展。
31-year-old male, 3-year hyperuricemia with early renal urate crystal deposition on ultrasound. Early intervention is critical. After KC-miRNA, UA dropped to 310 μmol/L, follow-up ultrasound showed partial dissolution of renal crystals, preventing chronic gout and kidney damage progression.
T
唐女士 · 49歲女 · 病程7年 / Beijing
術前尿酸
580 μmol/L
術後尿酸
330 μmol/L
✓ 尿酸降低43% · 停經期穩定代謝
49歲圍絕經期女性,7年高尿酸合併骨質疏鬆。雌激素水平下降導致尿酸排泄減少,形成惡性循環。KC-miRNA通過調節尿酸代謝通路,打破了「圍絕經期高尿酸」的難題。治療後尿酸降至330μmol/L,骨密度檢查顯示骨質疏鬆進展停滯,實現了代謝綜合管理。
49-year-old perimenopausal woman, 7-year hyperuricemia with osteoporosis. Declining estrogen reduces UA excretion. KC-miRNA broke the perimenopausal hyperuricemia cycle. Post-treatment UA at 330 μmol/L, bone density stabilization achieved — comprehensive metabolic management.

患者心聲

Voices from Our Patients

「就算自費,第二次手術也要回泰心醫院找路主任!日本專家說第一次手術做得非常漂亮、完美。」

"Even at my own expense, I'll return to TEDANCD for the second surgery! Japanese specialists said the first surgery was perfect."

小浩媽媽 · 江蘇 / Japan

「這第二條命是劉院長、是泰心醫院給的。為了我爸媽活著,也為了救我的這些醫護人員活著。」

"Dr. Liu and TEDANCD gave me my second life. I live for my parents and for the medical team who saved me."

張先生 · 吉林 / Jilin

「長達6000公里的旅途,在發病的關鍵時刻,幸運地守著這樣專業的醫院。一定是命運對我格外眷顧。」

"After 6,000 km of travel, I was fortunate to be near such a professional hospital at the critical moment. Fate was kind to me."

周先生 · 雲南 / Yunnan

「劉院長的抖音我每一條都翻看過,從他的話裡,我感受到了真誠。即便這次死在了路上,我也認了!」

"I watched every one of President Liu's Douyin videos. I felt his sincerity. Even if I died on the way here, I'd accept it!"

張先生 · 吉林 / Jilin

「從全國沒人敢收,到日本專家點讚,泰心醫院給了我們希望。這兒的醫護人員就是孩子的重生貴人!」

"From being rejected nationwide to praise from Japanese specialists — TEDANCD gave us hope. The staff are our child's angels of rebirth!"

小浩媽媽 · 江蘇 / Jiangsu

「泰達的國際服務團隊讓我感到安心。從機場接機到出院返程,全程有人陪同翻譯。」

"TEDANCD's international service team made me feel at ease. From airport pickup to discharge, there was always someone accompanying and translating."

陳先生 · 馬來西亞 / Malaysia

開始您的逆轉之旅

讓我們幫您寫下下一個成功故事。